SCHEMBL14017677

SCHEMBL14017677

CC(C)(C)OC(=O)N[C@H]1CCN(Cc2ccn3ncnc(Oc4ccc(N)cc4F)c23)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 3/20 0.57
MET P08581 14/20 0.53
NTRK1 P04629 1/20 0.51
SCN9A Q15858 1/20 0.45
EGFR P00533 3/20 0.40
ERBB2 P04626 2/20 0.40
CIT O14578 1/20 0.39
CHEK1 O14757 1/20 0.39
GAK O14976 1/20 0.39
STK10 O94804 1/20 0.39
PRKD3 O94806 1/20 0.39
ABL1 P00519 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
YES1 P07947 1/20 0.39
LYN P07948 1/20 0.39
RET P07949 1/20 0.39
HCK P08631 1/20 0.39
SRC P12931 1/20 0.39
PHKG2 P15735 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14017676 1.00 AAK1 (0.57) AAK1METNTRK1SCN9AEGFR
SCHEMBL14017679 0.96 AAK1 (0.54) AAK1METNTRK1SCN9A
SCHEMBL4811602 0.95 AAK1 (0.63) AAK1METNTRK1EGFRERBB2
SCHEMBL4822868 0.90 MET (0.56) AAK1METNTRK1EGFRERBB2
SCHEMBL14017672 0.87 MET (0.55) AAK1METNTRK1EGFRERBB2
SCHEMBL4810959 0.86 MET (0.53) AAK1METNTRK1EGFRERBB2
SCHEMBL14017710 0.86 MET (0.54) AAK1METNTRK1EGFRERBB2
SCHEMBL4817297 0.85 MET (0.61) AAK1METNTRK1EGFRERBB2
SCHEMBL4819894 0.81 MET (0.62) AAK1METNTRK1EGFRERBB2
SCHEMBL15946933 0.80 MET (0.54) AAK1METNTRK1EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439246-B2 Fused heterocyclic kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-10-21 US disclosed
US-7439246-B2 Fused heterocyclic kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-10-21 US disclosed
US-7173031-B2 Pyrrolotriazine kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-06 US disclosed